Multi-valve detection — mitral, tricuspid, and aortic — built on the same research foundation that produced the company's cleared products. Mitral regurgitation detection was published in Circulation (2024). Tricuspid regurgitation detection was published in JAMA Cardiology (2025). Aortic valve work is in active development. Mitral and tricuspid in clinical validation; aortic in development.
Product typeDiagnostics & Imaging
Pricing ·
Deployment
APINot available
What teams use Pipeline: Valve Disease for
Automated echocardiographic LVEF measurement
AI screening for cardiac amyloidosis
Opportunistic liver disease screening from echocardiography